{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:08:37Z","timestamp":1794344917608,"version":"4.9.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:p>Most of salivary gland neoplasms (benign and malignant) are characterized by recurrent gene fusions. Pleomorphic adenoma (PA), the most frequent salivary gland tumor, is driven by chromosomal rearrangements involving <jats:italic toggle=\"yes\">PLAG1<\/jats:italic> mapped to 8q12 and <jats:italic toggle=\"yes\">HMGA2<\/jats:italic> mapped to 12q13-15 in most cases. Multiple fusion partners have been identified including <jats:italic toggle=\"yes\">CTNNB1<\/jats:italic>, <jats:italic toggle=\"yes\">FGFR1<\/jats:italic>, <jats:italic toggle=\"yes\">LIFR<\/jats:italic>, <jats:italic toggle=\"yes\">CHCHD7<\/jats:italic> and <jats:italic toggle=\"yes\">TCEA<\/jats:italic> for <jats:italic toggle=\"yes\">PLAG1<\/jats:italic> fusions and <jats:italic toggle=\"yes\">NFIB<\/jats:italic>, <jats:italic toggle=\"yes\">WIF1<\/jats:italic> and <jats:italic toggle=\"yes\">FHIT<\/jats:italic> for <jats:italic toggle=\"yes\">HMGA2<\/jats:italic> fusions. To date, no data exist on the morphology of the few reported <jats:italic toggle=\"yes\">HMGA2-WIF1-<\/jats:italic>rearranged PAs. We present 28 major salivary gland adenomas displaying distinctive trabecular and canalicular morphology associated with recurrent genotype. Patients were 15 females and 13 males aged 43 to 87 (median: 65). All tumors originated from the parotid. Their size range was 1 to 4\u2009cm (mean: 2.3). Histologically, all tumors showed elongated or columnar cells arranged into bilayered to multilayered communicating and branching strands and trabeculae in a manner similar to canalicular adenoma of minor salivary glands or trabecular myoepithelioma with variable solid confluent intercalated duct-like areas. Fifteen tumors were exclusively canalicular\/trabecular while 13 had intermingled or well-demarcated conventional (chondromyxoid) PA component comprising 5 to &gt;50% of the tumor. The monomorphic areas expressed uniformly CK7 (28\/28), vimentin (21\/21), S100 (24\/24), SOX10 (16\/17) and variably p63 (8\/21) and mammaglobin (6\/16) but were negative with p40 (0\/24), smooth muscle actin (0\/24) and MUC4 (0\/16). Targeted RNA sequencing revealed <jats:italic toggle=\"yes\">HMGA2<\/jats:italic> fusions in 14\/16 (87%) assessable cases. Fusion partner was <jats:italic toggle=\"yes\">WIF1<\/jats:italic> (12), <jats:italic toggle=\"yes\">RPSAP52<\/jats:italic> (1) and <jats:italic toggle=\"yes\">HELB<\/jats:italic> (1). Separate testing of the 2 components in 1 hybrid tumor showed same <jats:italic toggle=\"yes\">HMGA2\/WIF1<\/jats:italic> fusion. HMGA2 immunohistochemistry was homogeneously positive in all cases including the 2 fusion-negative cases. A control cohort of 12 genuine canalicular adenomas revealed no <jats:italic toggle=\"yes\">HMGA2<\/jats:italic> fusions (0\/4) and lacked HMGA2 immunoreactivity (0\/12). This study highlights a distinctive variant in the spectrum of PA characterized by prominent trabecular and canalicular adenoma-like morphology. Our data confirm that canalicular adenomas in major salivary glands (either monomorphic or part of hybrid tumors) are distinct from canalicular adenoma of minor salivary glands. Their uniform genotype irrespective of presence or absence of a conventional PA component argues for classifying those tumors lacking a conventional PA component as \u201cmonomorphic variants of PA\u201d rather than canalicular\/basal cell adenomas, intercalated duct adenoma, trabecular myoepithelioma or true hybrid tumors.<\/jats:p>","DOI":"10.1097\/pas.0000000000001783","type":"journal-article","created":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T21:02:37Z","timestamp":1627592557000},"page":"190-199","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":59,"title":["HMGA2-WIF1 Rearrangements Characterize a Distinctive Subset of Salivary Pleomorphic Adenomas With Prominent Trabecular (Canalicular Adenoma-like) Morphology"],"prefix":"10.1097","volume":"46","author":[{"given":"Abbas","family":"Agaimy","sequence":"first","affiliation":[{"name":"Institute of Pathology, Comprehensive Cancer Center (CCC) Erlangen-EMN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ihrler","sequence":"additional","affiliation":[{"name":"DERMPATH Muenchen"},{"name":"Institute of Pathology, Ludwig Maximilians University, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Ban\u011b\u010dkov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Pathology, Charles University, Faculty of Medicine in Plzen"},{"name":"Bioptic Laboratory Ltd, Plzen, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Cost\u00e9s Martineau","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospital Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Mantsopoulos","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, Friedrich-Alexander-University Erlangen-N\u00fcrnberg, University Hospital Erlangen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt","family":"Hartmann","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Comprehensive Cancer Center (CCC) Erlangen-EMN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"Iro","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, Friedrich-Alexander-University Erlangen-N\u00fcrnberg, University Hospital Erlangen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Stoehr","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Comprehensive Cancer Center (CCC) Erlangen-EMN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Sk\u00e1lov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Pathology, Charles University, Faculty of Medicine in Plzen"},{"name":"Bioptic Laboratory Ltd, Plzen, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,7,29]]},"reference":[{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000479070","article-title":"Salivary gland neoplasms: does morphological diversity reflect tumor heterogeneity","volume":"85","author":"Rito","year":"2018","journal-title":"Pathobiology"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.semcancer.2005.01.002","article-title":"Fusion oncogenes and tumor type specificity\u2014insights from salivary gland tumors","volume":"15","author":"Stenman","year":"2005","journal-title":"Semin Cancer Biol"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/PAP.0b013e3182a92cc3","article-title":"Translocation-associated salivary gland tumors: a review and update","volume":"20","author":"Weinreb","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1097\/PAS.0000000000000980","article-title":"The role of molecular testing in the differential diagnosis of salivary gland carcinomas","volume":"42","author":"Sk\u00e1lov\u00e1","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"suppl 1","key":"R6-20250608","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1007\/s12105-013-0462-z","article-title":"Fusion oncogenes in salivary gland tumors: molecular and clinical consequences","volume":"7","author":"Stenman","year":"2013","journal-title":"Head Neck Pathol"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"e768","DOI":"10.1111\/aos.13667","article-title":"Recurrent rearrangements of the PLAG1 and HMGA2 genes in lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma","volume":"96","author":"Andreasen","year":"2018","journal-title":"Acta Ophthalmol"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/PAP.0000000000000291","article-title":"Molecular pathology of salivary gland neoplasms: diagnostic, prognostic, and predictive perspective","volume":"28","author":"Toper","year":"2021","journal-title":"Adv Anat Pathol"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/PAS.0000000000001280","article-title":"Metastasizing pleomorphic adenoma: recurrent PLAG1\/HMGA2 rearrangements and identification of a novel HMGA2-TMTC2 fusion","volume":"43","author":"Wasserman","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/gcc.20402","article-title":"WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors","volume":"46","author":"Queimado","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/gcc.20619","article-title":"High-resolution genomic profiling of adenomas and carcinomas of the salivary glands reveals amplification, rearrangement, and fusion of HMGA2","volume":"48","author":"Persson","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/PAS.0000000000000972","article-title":"Molecular profiling of mammary analog secretory carcinoma revealed a subset of tumors harboring a novel ETV6-RET translocation: report of 10 cases","volume":"42","author":"Skalova","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0167-4781(01)00215-9","article-title":"HMGI\/Y proteins: flexible regulators of transcription and chromatin structure","volume":"519","author":"Reeves","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/01.MP.0000092954.42656.94","article-title":"Fusion, disruption, and expression of HMGA2 in bone and soft tissue chondromas","volume":"16","author":"Dahl\u00e9n","year":"2003","journal-title":"Mod Pathol"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/gcc.22055","article-title":"Identification of PPAP2B as a novel recurrent translocation partner gene of HMGA2 in lipomas","volume":"52","author":"Bianchini","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3892\/ijo.2015.3099","article-title":"The recurrent chromosomal translocation t(12;18)(q14~15;q12~21) causes the fusion gene HMGA2-SETBP1 and HMGA2 expression in lipoma and osteochondrolipoma","volume":"47","author":"Panagopoulos","year":"2015","journal-title":"Int J Oncol"},{"key":"R17-20250608","doi-asserted-by":"crossref","DOI":"10.1038\/s41379-021-00789-8","article-title":"Recurrent novel HMGA2-NCOR2 gene fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors","author":"Agaimy","year":"2021","journal-title":"Mod Pathol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/18899","article-title":"A new secreted protein that binds to Wnt proteins and inhibits their activities","volume":"398","author":"Hsieh","year":"1999","journal-title":"Nature"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/path.1449","article-title":"WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer","volume":"201","author":"Wissmann","year":"2003","journal-title":"J Pathol"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41523-018-0101-7","article-title":"Assessment of HMGA2 and PLAG1 rearrangements in breast adenomyoepitheliomas","volume":"5","author":"Pareja","year":"2019","journal-title":"NPJ Breast Cancer"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41523-020-0164-0","article-title":"Pleomorphic adenomas and mucoepidermoid carcinomas of the breast are underpinned by fusion genes","volume":"6","author":"Pareja","year":"2020","journal-title":"NPJ Breast Cancer"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ijc.21400","article-title":"Wnt pathway is involved in pleomorphic adenomas induced by overexpression of PLAG1 in transgenic mice","volume":"118","author":"Zhao","year":"2006","journal-title":"Int J Cancer"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1258\/0022215053222824","article-title":"Canalicular adenoma of the parotid gland","volume":"119","author":"Philpott","year":"2005","journal-title":"J Laryngol Otol"},{"key":"R24-20250608","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.10.2008.1072","article-title":"Canalicular adenoma: a case report of an unusual parotid lesion","volume":"2009","author":"Butler","year":"2009","journal-title":"BMJ Case Rep"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0964-1955(95)00059-3","article-title":"Hybrid tumours of salivary glands. Definition and classification of five rare cases","volume":"32B","author":"Seifert","year":"1996","journal-title":"Eur J Cancer B Oral Oncol"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s12105-014-0560-6","article-title":"Canalicular adenoma: a clinicopathologic and immunohistochemical analysis of 67 cases with a review of the literature","volume":"9","author":"Thompson","journal-title":"Head Neck Pathol"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/his.13246","article-title":"HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma","volume":"71","author":"Mito","year":"2017","journal-title":"Histopathology"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001783","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T21:03:36Z","timestamp":1749416616000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,29]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001783","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,29]]}}}